Spine Care In Brief
This article was originally published in The Gray Sheet
Executive Summary
ArthroCare deal: Parallax bone access, augmentation and cement injection products exclusive worldwide distribution will commence Nov. 15 under an agreement to acquire parent firm Medical Device Alliance for $28 mil., plus revenue milestone payments. The devices are used in "a variety of orthopedic procedures, including treatments for vertebral compression fractures," the firm says. ArthroCare expects the purchase to close early next year and add $7-$8 mil. to sales. The company simultaneously unveiled its Cavity SpineWand Oct. 24 for use with its Coblation radiofrequency ablation technology to dissolve tissue growths in spinal structures. The device "can be used prior to common procedures including the treatment of spinal diseases requiring bone augmentation and percutaneous cement injection," ArthroCare claims...